In a potentially significant step forward in biopharmaceutical supply chain logistics, a collaboration between AT&T, Direct Relief, MSD and Softbox is testing the potential of drones to deliver temperature-dependent medicines…
Japan’s Opportunity to Establish a Blueprint for the World: Janssen Japan’s Chris Hourigan makes the case for increased investment in, and access to, innovative medicines as a key solution to…
Şükran Tümay, a senior partner at executive search and assessment firm Stanton Chase in Turkey, highlights the evolving profiles she looks for when hiring country managers for healthcare and the…
Rare diseases and cell and gene therapy executive recruitment specialist Steve Smith outlines six key strategies for attracting and retaining talent in these rapidly emerging fields. In a young…
Frost & Sullivan’s Senior Research Analyst, Aarti Chitale looks at the sizeable impact that precision medicine, especially regenerative medicine, is already having on the global therapeutic landscape, and how the…
Under Thailand’s Universal Coverage Scheme, Thai citizens at every stage of life are entitled to essential health services and 99% of its population are currently covered. This year, not resting…
Spanish plasma specialist Grifols is making a move to invest in Africa, and was recently selected as the supplier for Soludia Maghreb’s new plant in Morocco. The CEOs of both…
China’s rapidly-growing biotech sector is increasingly hungry for preclinical drug candidates to commercialise in China, and Chinese companies are spending top dollar for cutting-edge technology from the US and UK.…
Sweden, home of IKEA, Pippi Longstocking and Abba, is one of Europe’s most innovative and forward-thinking nations in the healthcare and life sciences sphere. Here are five top facts to…
Taiwan has long been a leader in biotechnology research and development. With the government’s emphasis on higher education and research, Taiwan has trained a diverse pool of talent in the…
Veeva Systems Europe’s Paul Attridge highlights how a switch to a continuous model for regulatory operations could allow biopharmaceutical companies to submit high-quality regulatory submissions for their products faster than…
PwC’s Kelly Barnes examines how the US pharmaceutical sector is having to rethink its relationship with consumers, experimenting with new and innovative pricing models, and adopting a more holistic view…
See our Cookie Privacy Policy Here
